Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic Cancer
- Robert W. Corty
- , Benjamin W. Langworthy
- , Jason P. Fine
- , John B. Buse
- , Hanna K. Sanoff
- , Jennifer L. Lund
Research output: Contribution to journal › Article › peer-review
36
Link opens in a new tab
Scopus
citations